Literature DB >> 12197852

Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression.

G Parker1.   

Abstract

OBJECTIVE: A possible mechanism whereby the serotonin reuptake inhibitor (SSRI) antidepressants may not (overall) be as effective as the tricyclic (TCA) antidepressants is explored.
METHOD: Clinical psychiatrists rated the effectiveness of past antidepressant medications in a clinical panel study of patients with a major depressive disorder, with 200 having previously received a TCA and 219 an SSRI.
RESULTS: Analyses indicated decreased SSRI effectiveness with age in those with the melancholic subtype. TCA effectiveness appeared uninfluenced by age and depressive subtype.
CONCLUSION: Findings suggest why the broader-based TCAs may be more effective than the SSRIs in implicating age and depressive subtype influences. Copyright Blackwell Munksgaard 2002.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12197852     DOI: 10.1034/j.1600-0447.2002.02432.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  5 in total

Review 1.  Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.

Authors:  Brian Draper; Karen Berman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

2.  Assessment of the Antidepressant Side Effects Occurrence in Patients Treated in Primary Care.

Authors:  Enisa Ramic; Subhija Prasko; Larisa Gavran; Emina Spahic
Journal:  Mater Sociomed       Date:  2020-06

Review 3.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

Review 4.  Core symptoms of major depressive disorder: relevance to diagnosis and treatment.

Authors:  Sidney H Kennedy
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

5.  Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study.

Authors:  Kristin Köhler-Forsberg; Brice Ozenne; Søren V Larsen; Asbjørn S Poulsen; Elizabeth B Landman; Vibeke H Dam; Cheng-Teng Ip; Anders Jørgensen; Claus Svarer; Gitte M Knudsen; Vibe G Frokjaer; Martin B Jørgensen
Journal:  Transl Psychiatry       Date:  2022-07-11       Impact factor: 7.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.